Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	228	206	408	232	266	162
Market Cap Growth	-66.89%	-49.34%	75.40%	-12.74%	63.98%	-25.44%
Enterprise Value	110	79	249	18	204	104
PE Ratio	-	-5.50	-6.57	-4.02	-7.09	-2.67
PB Ratio	2.00	1.72	2.70	1.13	4.47	3.38
P/FCF Ratio	-6.24	-6.81	-7.19	-5.46	-7.10	-3.61
P/OCF Ratio	-6.24	-6.81	-7.20	-5.46	-7.10	-3.61
EV/EBITDA Ratio	-2.72	-2.25	-4.15	-0.33	-5.65	-1.69
EV/EBIT Ratio	-2.69	-2.24	-4.13	-0.33	-5.64	-1.69
EV/FCF Ratio	-2.44	-2.61	-4.40	-0.43	-5.43	-2.31
Debt / Equity Ratio	0.14	0.13	0.11	0.08	0.26	0.31
Debt / EBITDA Ratio	-0.57	-0.44	-0.27	-0.28	-0.42	-0.24
Debt / FCF Ratio	-0.51	-0.52	-0.28	-0.37	-0.41	-0.33
Quick Ratio	6.14	6.42	11.35	19.52	6.27	5.68
Current Ratio	6.50	6.64	11.79	19.77	6.69	5.82
Interest Coverage	-13.44	-17.12	-35.61	-32.16	-18.97	-101.90
Return on Equity (ROE)	-24.70%	-29.40%	-36.60%	-29.40%	-66.80%	-99.40%
Return on Assets (ROA)	-20.30%	-24.20%	-31.20%	-26.10%	-49.00%	-77.30%
Return on Capital (ROIC)	-27.41%	-31.59%	-37.51%	-25.37%	-48.67%	-100.38%
Earnings Yield	-13.22%	-18.18%	-15.22%	-24.86%	-14.10%	-37.45%
FCF Yield	-13.59%	-14.69%	-13.90%	-18.32%	-14.08%	-27.70%
Buyback Yield / Dilution	-1.06%	-0.92%	-8.07%	-59.11%	-25.28%	-25.02%
Total Shareholder Return	-1.06%	-0.92%	-8.07%	-59.11%	-25.28%	-25.02%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).